MX9203654A - Purificacion, clonacion y caracterizacion del gen para la interleucina i. - Google Patents

Purificacion, clonacion y caracterizacion del gen para la interleucina i.

Info

Publication number
MX9203654A
MX9203654A MX9203654A MX9203654A MX9203654A MX 9203654 A MX9203654 A MX 9203654A MX 9203654 A MX9203654 A MX 9203654A MX 9203654 A MX9203654 A MX 9203654A MX 9203654 A MX9203654 A MX 9203654A
Authority
MX
Mexico
Prior art keywords
new
interleukin
amino acid
cloning vector
gene
Prior art date
Application number
MX9203654A
Other languages
English (en)
Inventor
Douglas Pat Cerretti
Paul Jerome Conlon
David John Cosman
Kenneth Howard Grabstein
Thomas Patrick Hopp
Shirley R Kronneim
Alf D Larsen
Carl Jack March
Virginia Lee Price
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27542003&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203654(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/676,533 external-priority patent/US5484887A/en
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of MX9203654A publication Critical patent/MX9203654A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/545IL-1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
MX9203654A 1984-06-19 1992-06-26 Purificacion, clonacion y caracterizacion del gen para la interleucina i. MX9203654A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62220184A 1984-06-19 1984-06-19
US63500684A 1984-07-27 1984-07-27
US67455584A 1984-11-26 1984-11-26
US06/676,533 US5484887A (en) 1984-06-19 1984-11-30 Homogeneous interleukin 1
US68764684A 1984-12-31 1984-12-31

Publications (1)

Publication Number Publication Date
MX9203654A true MX9203654A (es) 1992-07-01

Family

ID=27542003

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203654A MX9203654A (es) 1984-06-19 1992-06-26 Purificacion, clonacion y caracterizacion del gen para la interleucina i.

Country Status (10)

Country Link
EP (2) EP0456332B1 (es)
JP (3) JP3217698B2 (es)
AT (2) ATE84547T1 (es)
AU (1) AU579142B2 (es)
CA (2) CA1341433C (es)
DE (2) DE3588224T2 (es)
DK (2) DK168048B1 (es)
IE (1) IE61353B1 (es)
MX (1) MX9203654A (es)
NZ (1) NZ211386A (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998578A (en) * 1984-05-18 1999-12-07 New England Medical Center Hospitals, Inc. Biologically active fragments of IL-1β
EP0569687B1 (en) * 1984-05-18 2002-08-21 New England Medical Center Hospitals, Inc. Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins
DE3588241T2 (de) * 1984-05-18 2002-12-05 Massachusetts Institute Of Technology, Cambridge Menschliche IL-1 cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren
US5342614A (en) * 1984-12-21 1994-08-30 Otsuka Pharmaceutical Co., Ltd. Method of treating arthritus or inflammation with IL-1β or derivatives thereof
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
US6107465A (en) * 1984-12-21 2000-08-22 Otsuka Pharmaceutical Co., Ltd. IL-1β and derivatives thereof and drugs
DE3587605T2 (de) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 und dessen Derivat.
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
US5831022A (en) * 1986-02-18 1998-11-03 Hoffmann-La Roche Inc. Purification of recombinant human IL-1α
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
US4801686A (en) * 1986-09-04 1989-01-31 Immunex Corporation Purification of recombinant interleukin-1
US5047505A (en) * 1987-01-27 1991-09-10 Du Pont Merck Pharmaceutical Company High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity
US4894333A (en) * 1987-05-28 1990-01-16 Immunex Corporation Bovine interleukin-1α
AU5355790A (en) * 1989-04-19 1990-11-16 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
GB9010356D0 (en) * 1990-05-09 1990-06-27 Ciba Geigy Ag Maturation of hemopoietic cells
DE69229252T2 (de) * 1991-08-16 1999-12-16 Merck & Co., Inc. DNS, welche das Interleukin-1B-Vorläufer-Converting-Enzym kodiert
CA2469492C (en) * 2001-12-11 2012-10-16 University Of Medicine And Dentistry Of New Jersey Diagnostic methods for protein profiling
KR20090052355A (ko) * 2006-08-14 2009-05-25 시코르, 인크. 순도가 높은 페메트렉세드 이산 및 이의 제조 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3378128D1 (en) * 1982-04-20 1988-11-03 Sloan Kettering Inst Cancer Purification of interleukin 2
DE3588241T2 (de) * 1984-05-18 2002-12-05 Massachusetts Institute Of Technology, Cambridge Menschliche IL-1 cDNS-Sequenzen die für biologisch aktive menschliche IL-1-Proteine kodieren
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
AU577856B2 (en) * 1985-01-17 1988-10-06 Immunex Corporation Cloning and characterization of the human interleukin 1 gene

Also Published As

Publication number Publication date
DE3588224D1 (de) 2000-09-14
ATE195344T1 (de) 2000-08-15
IE850614L (en) 1986-09-08
NZ211386A (en) 1989-04-26
DK168048B1 (da) 1994-01-24
DK37293D0 (da) 1993-03-30
DK110485A (da) 1985-12-20
EP0456332B1 (en) 2000-08-09
JP2000060577A (ja) 2000-02-29
EP0456332A1 (en) 1991-11-13
JP3009381B2 (ja) 2000-02-14
JP3217698B2 (ja) 2001-10-09
DK37293A (da) 1993-03-30
ATE84547T1 (de) 1993-01-15
EP0165654A2 (en) 1985-12-27
JPH10279598A (ja) 1998-10-20
DE3586972T2 (de) 1993-07-08
IE61353B1 (en) 1994-11-02
CA1341433C (en) 2003-06-24
DE3586972D1 (de) 1993-02-25
DE3588224T2 (de) 2001-10-25
JPH09118697A (ja) 1997-05-06
AU3986385A (en) 1986-01-02
EP0165654B1 (en) 1993-01-13
CA1340978C (en) 2000-05-02
AU579142B2 (en) 1988-11-17
EP0165654A3 (en) 1988-05-04
DK110485D0 (da) 1985-03-11

Similar Documents

Publication Publication Date Title
MX9203654A (es) Purificacion, clonacion y caracterizacion del gen para la interleucina i.
Allen et al. A family of structural genes for human lymphoblastoid (leukocyte-type) interferon
Narita et al. The amino acid sequence of cardiotoxin from Formosan cobra (Naja naja atra) venom
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
CA2067744A1 (en) The human c3b/c4b receptor (cr1)
WETZEL et al. Properties of a human alpha-interferon purified from E. coli extracts
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
ZA907693B (en) The human c3b/c4b receptor(cr1)
DK165988B (da) Modificerede egliner b og c, deres anvendelse som proteaseinhibitorer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende de modificerede egliner b og c
KR880009125A (ko) 재조합 숙주에 의해 제조되는 췌장분비 트립신 억제제 및 그의 변이체, 그의 방법, 표현벡터 및 재조합 숙주 및 그의 제약상 용도
Schmelzer et al. Biochemical characterization of recombinant human nerve growth factor
Klippenstein et al. The primary structure of myohemerythrin
KR940005798A (ko) 지방세포화 억제 인자 유도체, 그의 제조방법 및 용도
ATE175719T1 (de) Epididymis-spezifische polypeptide und deren verwendung
Ueno et al. Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor
Francis et al. Carboxyl-terminal amino acid sequences of two variant forms of the gamma chain of human plasma fibrinogen.
CA2072587A1 (en) Oxidized variants of gm-csf
Lauren et al. Covalent dimerization of recombinant human interferon-γ
JPH0564588A (ja) 短い重鎖を有するヒトプロテインcおよび活性化ヒトプロテインc
Aggarwal et al. [34] Human tumor necrosis factor
MARDER Carboxyl-terminal amino acid sequences of two variant forms of the y chain of human plasma fibrinogen
DK200200302A (da) Rekombinante polypeptider omfattende aminosyresekvensen af moden vævsfaktorinhibitor (TFI), polypeptidfragmenter deraf, ekspressionsvektorer der koder for disse, værtsceller transformeret dermed, og fremgangsmåde til fremstilling af et ........
Song Purification and characterization of papaya latex glutaminyl cyclase and molecular cloning, sequence analysis, and expression of human pituitary glutaminyl cyclase.
TH1778EX (th) สารคล้ายคลึง จี อาร์ เอฟ (grf)
TH12889A (th) เคอร์คูลิน บี และคีเอ็นเอที่เป็นรหัสของสารดังกล่าว และขบวนการสำหรับการผลิตสารดังกล่าว